Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

The new assay can help develop products for hair re-growth.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The retinoid receptor antagonist effectively disrupts vitamin A-related development in embryos.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Pranlukast and mirabegron may work as new diabetes drugs.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A new compound may treat benign prostatic hyperplasia better than finasteride.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

RU 58841 may treat acne, hair loss, and excessive hair growth.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.